Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder.

van Wilpe, Sandra; Gerretsen, Eveline C F; van der Heijden, Antoine G; de Vries, I Jolanda M; Gerritsen, Winald R; Mehra, Niven

van Wilpe, Sandra; Gerretsen, Eveline C F; van der Heijden, Antoine G; de Vries, I Jolanda M; Gerritsen, Winald R; Mehra, Niven.

Afiliação

van Wilpe S; Department of Medical Oncology, the Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Gerretsen ECF; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
van der Heijden AG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
de Vries IJM; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Gerritsen WR; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, the Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

Cancers (Basel) ; 12(9)2020 Sep 21.

Article em En | MEDLINE | ID: mdl-32967190

Palavras-chave

biomarkers; checkpoint inhibitors; chemotherapy; prognosis; urothelial cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google